Mangeet Kaur Bouns
Latest: Page 14
3 Falling Stock to Think About Selling Short Right Now
Worries about sky-high inflation, the Federal Reserve's hawkish stance, and recession prospects have spurred market sell-off lately. Moreover, investors expect increased market volatility as analysts cut down their earnings estimates....
NERV Stock Is on the Move, but Is It a Buy?
Biopharmaceutical company Minerva Neurosciences (NERV) delivered considerable losses in its last quarter. Investors are increasingly concerned about the company's massive debt burden and increased cash burn. Despite its limited earnings...
Cathie Wood Doubled Down on This Biotech Stock, Should You?
Biotech company Ginkgo Bioworks' (DNA) top-line growth didn't translate into bottom-line improvement in its last quarter. The stock is currently trading approximately 84% below its 52-week high, and analysts expect...
Stay as Far Away as Possible From This Meme Stock
Outdoor cooking company Weber (WEBR) reported deteriorating third-quarter financials. Moreover, the company has suspended its quarterly cash dividend and withdrawn its fiscal 2022 net sales and earnings outlook, as high...
Is SoFi Stock a Buy as Biden Forgives Student Loans?
金融服务公司索菲技术(索菲) reported disappointing second-quarter financials, and the stock is currently trading more than 75% below its 52-week high. Furthermore, analysts are bearish about the company's...
3 Stocks to Prepare Your Portfolio for the Next Black Swan Event
Black swan events are world-changing events that are rare and unpredictable and have outcomes with devastating effects. These events have severe implications for financial markets and investment portfolios. While investors...
